Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence
Carlo Fischer(Humboldt-Universität zu Berlin), Jan Felix Drexler(Humboldt-Universität zu Berlin), Manoel Sarno(Complexo Hospitalar Universitário Professor Edgard Santos), Alvaro Schwalb(London School of Hygiene & Tropical Medicine), Edmilson Ferreira de Oliveira-Filho(University of Liège), Xiomara Merino(Universidad Peruana Cayetano Heredia), Eduardo Martins Netto(Universidade Federal da Bahia), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Michael Talledo(Universidad Peruana Cayetano Heredia), Xavier de Lamballerie(Inserm), Célia Pedroso(Complexo Hospitalar Universitário Professor Edgard Santos), Fernando A. Bozza(D’Or Institute for Research and Education), Andrés Moreira‐Soto(Humboldt-Universität zu Berlin), Eduardo Gotuzzo(Universidad Peruana Cayetano Heredia), Carlos Brites(Universidade Federal da Bahia)
Cited by 35
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527